Related Experiment Video
Updated: Jan 8, 2026

An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
Published on: October 20, 2018
Beyond the Michaelis-Menten: Evaluation of a tQSSA-Based IVIVE Approach for Predicting In Vivo Intrinsic Clearance
Ngoc-Anh Thi Vu1,2, Yun Min Song3,4, Sang Kyum Kim1,2
1College of Pharmacy, Chungnam National University, Daejeon, Korea.
Abstract:
The classical Michaelis-Menten model, under the standard quasi-steady-state approximation (sQSSA), is widely used in in vitro-in vivo extrapolation (IVIVE) studies using hepatocyte or human liver microsomal (HLM) assays to predict intrinsic hepatic clearance ( ). However, the approximation that enzyme concentration ( ) is much lower than the Michaelis constant ( ) does not always hold true, especially for low compounds or enzyme induction scenarios, leading to inaccurate predictions. To improve the accuracy of IVIVE predictions, the total quasi-steady-state approximation (tQSSA) which accounts for enzyme saturation when is not negligible relative to was first applied to HLM data and confirmed that it improved clearance prediction compared with the sQSSA. Building on this, we further evaluated the performance of tQSSA using hepatocyte data. The in vivo intrinsic hepatic clearance was predicted using both the sQSSA and tQSSA with the well-stirred and parallel tube models. Predictions were evaluated across three scenarios: (1) using both the unbound fraction in blood ( ) and the in vitro hepatocyte incubation system ( ), (2) using only , and (3) without correction. Results showed that the sQSSA tended to overpredict clearance when ≥ . In the 77-compound dataset, the tQSSA yielded slightly better agreement, particularly when = = 1, whereas with mechanistic binding corrections both models performed similarly. For the 11-compound subset with known values, the proportion within 2-fold error improved by about 1.5-fold compared with sQSSA. Overall, tQSSA appears promising but requires further validation for IVIVE applications.
More Related Videos
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
07:30Assessing Insulin Clearance in Mice via In Situ Liver Perfusion
Published on: December 13, 2024
Related Concept Videos
Drug Product Performance: In Vitro–In Vivo Correlation
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Measurement of Bioavailability: Pharmacodynamic Methods
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
Measurement of Bioavailability: Pharmacokinetic Methods